Mouse Pain Assay
Mouse Pain Assay - Related Videos
09:26
The Monoiodoacetate Model of Osteoarthritis Pain in the Mouse
0 Views •
Cited by 181 •
2016
Osteoarthritis (OA), or degenerative joint disease, is a debilitating condition associated with pain that remains only partially controlled by available analgesics. Animal models are being developed to improve our understanding of OA-related pain mechanisms. Here we describe the methodology for the monoiodoacetate model of OA pain in the mouse.
02:26
Intracranial Pharmacotherapy and Pain Assays in Rodents
0 Views •
2019
Here we present a protocol to perform intracranial pharmacological experiments followed by pain behavior assays in rodents. This protocol allows researchers to deliver molecular and cellular targets in the brain, for pharmacologic agents in the treatment of pain.
01:34
Early Intervention and Pain Management
0 Views •
2026
All animal procedures described here must be conducted in accordance with institutional animal ethics guidelines and approved by IACUC. All procedures must follow the principles of the 3Rs—Replacement, Reduction, and Refinement—and must be performed by trained personnel. Monitoring Animals for Signs of Pain and Distress Recognizing early signs of pain is essential for ethical animal research. Animals are routinely monitored using behavioral, physical, and physiological parameters that reflect...
06:57
Mechanical Conflict-Avoidance Assay to Measure Pain Behavior in Mice
0 Views •
Cited by 10 •
2022
The mechanical conflict-avoidance assay is used as a non-reflexive readout of pain sensitivity in mice which can be used to better understand affective-motivational responses in a variety of mouse pain models.
11:46
Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice
0 Views •
Cited by 19 •
2014
Approximately 3-8 million people in the United States suffer from interstitial cystitis/bladder pain syndrome (IC/BPS), a debilitating condition characterized in part by pelvic pain. In order to study nervous system contributions to the condition, a physiological model of urinary bladder pain is used in mice and rats.
FAQs
Thermal, mechanical, and chemical challenges probe different stimulus classes, so the measured behavior should be interpreted in relation to the challenge used. A paw withdrawal, licking, guarding, or facial grimace is not interchangeable as an endpoint. Comparing responses within the same assay and stimulus framework helps distinguish changes in sensory reactivity from differences created by the measurement itself.
Stimulus intensity and the selected behavioral endpoint shape how nociception appears in the dataset. Activation of nociceptors can produce rapid withdrawal or more sustained behaviors such as guarding and facial grimacing. Recording the response against baseline and controls helps determine whether an observed change reflects altered pain signaling rather than normal behavioral variation.
Mouse Pain Assay results can be used to distinguish acute from persistent pain-related states, but interpretation depends on timing and the behavior recorded. Rapid withdrawal may capture an immediate response, whereas guarding or grimacing can provide information about ongoing pain-related behavior. This distinction is useful when relating behavioral data to molecular pathways or disease biology.
An informative workflow begins with baseline measurements, applies the selected thermal, mechanical, or chemical challenge, and then records predefined responses. Researchers compare treated animals with appropriate controls and evaluate changes in behaviors such as withdrawal, licking, guarding, or grimacing. Keeping the stimulus type, scoring approach, and comparison conditions consistent supports interpretable measurements across experimental groups.
To evaluate a potential analgesic, investigators can compare behavioral responses across treatment groups and doses, using baseline and control measurements as reference points. Reduced pain-related behavior may indicate efficacy, while differences across doses help characterize a dose response. The assay therefore supports pharmacology studies without treating a single behavioral outcome as a complete description of pain.
Good experimental design combines controls with humane endpoints. Controls establish the behavioral range against which treatment effects are judged, while humane endpoints limit avoidable distress during testing. These safeguards are scientifically important as well as ethical: uncontrolled variation or excessive stimulation can complicate interpretation and weaken comparisons between groups in neuroscience, pharmacology, and disease biology.